» Articles » PMID: 38689075

Delivery-mediated Exosomal Therapeutics in Ischemia-reperfusion Injury: Advances, Mechanisms, and Future Directions

Overview
Journal Nano Converg
Specialty Biotechnology
Date 2024 Apr 30
PMID 38689075
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemia-reperfusion injury (IRI) poses significant challenges across various organ systems, including the heart, brain, and kidneys. Exosomes have shown great potentials and applications in mitigating IRI-induced cell and tissue damage through modulating inflammatory responses, enhancing angiogenesis, and promoting tissue repair. Despite these advances, a more systematic understanding of exosomes from different sources and their biotransport is critical for optimizing therapeutic efficacy and accelerating the clinical adoption of exosomes for IRI therapies. Therefore, this review article overviews the administration routes of exosomes from different sources, such as mesenchymal stem cells and other somatic cells, in the context of IRI treatment. Furthermore, this article covers how the delivered exosomes modulate molecular pathways of recipient cells, aiding in the prevention of cell death and the promotions of regeneration in IRI models. In the end, this article discusses the ongoing research efforts and propose future research directions of exosome-based therapies.

Citing Articles

Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia.

Ravi Mythili V, Rajendran R, Arun R, Loganathbabu V, Reyaz D, Nagarajan A Bioengineering (Basel). 2025; 12(1).

PMID: 39851366 PMC: 11762151. DOI: 10.3390/bioengineering12010092.


Exosome Loaded in Microneedle Patch Ameliorates Renal Ischemia-Reperfusion Injury in a Mouse Model.

Taghavi S, Keshtkar S, Abedanzadeh M, Hashemi M, Heidari R, Abolmaali S Stem Cells Int. 2025; 2025():3106634.

PMID: 39845407 PMC: 11753846. DOI: 10.1155/sci/3106634.


Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.

Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F Signal Transduct Target Ther. 2024; 9(1):271.

PMID: 39396974 PMC: 11486532. DOI: 10.1038/s41392-024-01969-z.


Applications of plant-derived extracellular vesicles in medicine.

Zhu Y, Zhao J, Ding H, Qiu M, Xue L, Ge D MedComm (2020). 2024; 5(10):e741.

PMID: 39309692 PMC: 11413507. DOI: 10.1002/mco2.741.


Astrocyte-derived exosomal miR-378a-5p mitigates cerebral ischemic neuroinflammation by modulating NLRP3-mediated pyroptosis.

Sun R, Liao W, Lang T, Qin K, Jiao K, Shao L Front Immunol. 2024; 15:1454116.

PMID: 39176087 PMC: 11338813. DOI: 10.3389/fimmu.2024.1454116.

References
1.
Huang J, Cao H, Cui B, Ma X, Gao L, Yu C . Mesenchymal Stem Cells-Derived Exosomes Ameliorate Ischemia/Reperfusion Induced Acute Kidney Injury in a Porcine Model. Front Cell Dev Biol. 2022; 10:899869. PMC: 9171021. DOI: 10.3389/fcell.2022.899869. View

2.
Yu B, Kim H, Gong M, Wang J, Millard R, Wang Y . Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol. 2015; 182:349-60. PMC: 4382384. DOI: 10.1016/j.ijcard.2014.12.043. View

3.
Sahoo S, Kariya T, Ishikawa K . Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol. 2021; 18(6):389-399. PMC: 8140998. DOI: 10.1038/s41569-020-00499-9. View

4.
Dare A, Logan A, Prime T, Rogatti S, Goddard M, Bolton E . The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model. J Heart Lung Transplant. 2015; 34(11):1471-80. PMC: 4626443. DOI: 10.1016/j.healun.2015.05.007. View

5.
Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View